Coleman E, Radix AE, Bouman WP et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Trans Health 23(Suppl 1):S1–S259. https://doi.org/10.1080/26895269.2022.2100644

Article  CAS  Google Scholar 

Herman JL, Flores AR, O’Neill KK (2022) How Many Adults and Youth Identify as Transgender in the United States?

Obedin-Maliver J, Goldsmith ES, Stewart L et al (2011) Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA. https://doi.org/10.1001/jama.2011.1255

Article  PubMed  Google Scholar 

Dahlhamer JM, Galinsky AM, Joestl SS, Ward BW (2016) Barriers to health care among adults identifying as sexual minorities: a US national study. Am J Public Health 106(6):1116–1122. https://doi.org/10.2105/AJPH.2016.303049

Article  PubMed  PubMed Central  Google Scholar 

Lerner JE, Robles G (2017) Perceived barriers and facilitators to health care utilization in the United States for transgender people: a review of recent literature. J Health Care Poor Underserved 28(1):127–152. https://doi.org/10.1353/hpu.2017.0014

Article  PubMed  Google Scholar 

Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS (2023) Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract 19(5):e794–e800. https://doi.org/10.1200/OP.22.00681

Article  PubMed  Google Scholar 

Kiran T, Davie S, Singh D et al (2019) Cancer screening rates among transgender adults: cross-sectional analysis of primary care data. Can Family Phys MEDECIN de famille canadien 65(1):e30–e37

Google Scholar 

Oladeru OT, Ma SJ, Miccio JA et al (2022) Breast and cervical cancer screening disparities in transgender people. Am J Clin Oncol 45(3):116–121. https://doi.org/10.1097/COC.0000000000000893

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luehmann N, Ascha M, Chwa E et al (2022) A single-center study of adherence to breast cancer screening mammography guidelines by transgender and non-binary patients. Ann Surg Oncol 29(3):1707–1717. https://doi.org/10.1245/s10434-021-10932-z

Article  PubMed  Google Scholar 

National Academies of Sciences Engineering and Medicine (2020). In: White J, Sepulveda MJ, Patterson CJ (eds) Understanding the well-being of lgbtqi populations the national academies collection: reports funded by national institutes of health. The National Academies Press, Washington

Google Scholar 

Jackson SS, Han X, Mao Z et al (2021) Cancer stage, treatment, and survival among transgender patients in the United States. J Natl Cancer Inst 113(9):1221–1227. https://doi.org/10.1093/jnci/djab028

Article  PubMed  PubMed Central  Google Scholar 

Griggs J, Maingi S, Blinder V et al (2017) American society of clinical oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol 35(19):2203–2208. https://doi.org/10.1200/JCO.2016.72.0441

Article  PubMed  Google Scholar 

Sakradse M, Zhu S, Ritterman Weintraub M, Jung J, Zaritsky E (2022) Hereditary breast and ovarian cancer genetic risk: screening and treatment among transgender and gender diverse patients. Perm J 26(3):30–38. https://doi.org/10.7812/TPP/21.133

Article  PubMed  PubMed Central  Google Scholar 

Bedrick BS, Fruhauf TF, Martin SJ, Ferriss JS (2021) Creating breast and gynecologic cancer guidelines for transgender patients with BRCA mutations. Obstet Gynecol 138(6):911–917. https://doi.org/10.1097/AOG.0000000000004597

Article  PubMed  Google Scholar 

Pearlman R, Frankel WL, Swanson BJ et al (2021) Prospective statewide study of universal screening for hereditary colorectal cancer: the ohio colorectal cancer prevention initiative. JCO Precision Oncol. https://doi.org/10.1200/PO.20.00525

Article  Google Scholar 

Ryan NAJ, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG, Crosbie EJ (2019) The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med 21(10):2167–2180. https://doi.org/10.1038/s41436-019-0536-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ligtenberg MJL, Kuiper RP, Geurts van Kessel A, Hoogerbrugge N (2013) EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients. Fam Cancer 12(2):169–174. https://doi.org/10.1007/s10689-012-9591-x

Article  CAS  PubMed  Google Scholar 

Win AK, Jenkins MA, Dowty JG et al (2017) Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomark Prev 26(3):404–412. https://doi.org/10.1158/1055-9965.EPI-16-0693

Article  CAS  Google Scholar 

Møller P, Seppälä TT, Bernstein I et al (2018) Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the prospective Lynch syndrome database. Gut 67(7):1306–1316. https://doi.org/10.1136/gutjnl-2017-314057

Article  PubMed  Google Scholar 

Dominguez-Valentin M, Haupt S, Seppala TT et al (2023) Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. EClinicalMedicine 58:101909. https://doi.org/10.1016/j.eclinm.2023.101909

Article  PubMed  PubMed Central  Google Scholar 

Gupta S, Weiss JM, Burke CA, et al. (2022) NCCN Guidelines Version 2.2022 Genetic/Familial High-Risk Assessment: Colorectal. https://www.nccn.org/home/

Safer JD, Tangpricha V (2019) Care of the transgender patient. Annals Internal Med. https://doi.org/10.7326/AITC201907020

Article  Google Scholar 

Hembree WC, Cohen-Kettenis PT, Gooren L et al (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903. https://doi.org/10.1210/jc.2017-01658

Article  PubMed  Google Scholar 

Baker KE, Wilson LM, Sharma R, Dukhanin V, McArthur K, Robinson KA (2021) Hormone therapy, mental health, and quality of life among transgender people: a systematic review. J Endocr Soc. https://doi.org/10.1210/jendso/bvab011

Article  PubMed  PubMed Central  Google Scholar 

Masumori N, Baba T, Abe T, Niwa K (2021) What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence? Int J Urol 28(5):526–529. https://doi.org/10.1111/iju.14499

Article  CAS  PubMed  Google Scholar 

Irwig MS (2017) Testosterone therapy for transgender men. Lancet Diabetes Endocrinol 5(4):301–311. https://doi.org/10.1016/S2213-8587(16)00036-X

Article  CAS  PubMed  Google Scholar 

Schechter LS, Safa B (2018) Gender surgery: a truly multidisciplinary field. Clin Plastic Surg. https://doi.org/10.1016/j.cps.2018.05.001

Article  Google Scholar 

de Blok CJM, Klaver M, Wiepjes CM et al (2018) breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study. J Clin Endocrinol Metab 103(2):532–538. https://doi.org/10.1210/jc.2017-01927

Article  PubMed  Google Scholar 

Cocchetti C, Ristori J, Romani A, Maggi M, Fisher AD (2020) Hormonal Treatment strategies tailored to non-binary transgender individuals. J Clin Med. https://doi.org/10.3390/jcm9061609

Article  PubMed  PubMed Central  Google Scholar 

Fernandez E, La Vecchia C, Braga C et al (1998) Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 7(4):329–333

CAS  PubMed  Google Scholar 

Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB (2009) Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 27(27):4542–4547. https://doi.org/10.1200/JCO.2009.22.0764

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson JR, Lacey JV Jr, Lazovich D et al (2009) Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 18(1):196–203. https://doi.org/10.1158/1055-9965.EPI-08-0596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang YC, Huang HL, Leung CY (2019) Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis. BMC Cancer 19(1):1199. https://doi.org/10.1186/s12885-019-6428-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Therkildsen C, Ladelund S, Smith-Hansen L, Lindberg LJ, Nilbert M (2017) Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types. Br J Cancer 117(11):1702–1710. https://doi.org/10.1038/bjc.2017.348

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Braun D, Ukaegbu C et al (2020) Clinical factors associated with gastric cancer in individuals with lynch syndrome. Clin Gastroenterol Hepatol 18(4):830–7.e1. https://doi.org/10.1016/j.cgh.2019.07.012

Article  CAS  PubMed  Google Scholar 

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262. https://doi.org/10.1038/ajg.2014.435

Article  PubMed  PubMed Central  Google Scholar 

Lopez DS, Malagaris I, Polychronopoulou E et al (2022) Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men. Clin Endocrinol 97(6):792–803. https://doi.org/10.1111/cen.14803

Article  CAS  Google Scholar 

Liu Q, Simin J, Debelius J et al (2021) Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study. Aliment Pharmacol Ther 53(11):1216–1225. https://doi.org/10.1111/apt.16362

Article  CAS  PubMed  Google Scholar 

Bosetti C, Bravi F, Negri E, La Vecchia C (2009) Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update 15(5):489–498. https://doi.org/10.1093/humupd/dmp017

Article  PubMed